Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/12/2014US8802881 Benzo lipoxin analogues
08/12/2014US8802868 Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
08/12/2014US8802865 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
08/12/2014US8802864 Triazolones as fatty acid synthase inhibitors
08/12/2014US8802861 Thiazole derivatives and use thereof
08/12/2014US8802860 Method for producing substituted pyridin-2-one
08/12/2014US8802858 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
08/12/2014US8802855 Method for preparation of iloperidone and crystallization method thereof
08/12/2014US8802854 Crystalline forms of Prasugrel salts
08/12/2014US8802853 Arylalkenyl and arylalkynyl substituted imidazoquinolines
08/12/2014US8802850 Cyclopropyl modulators of P2Y12 receptor
08/12/2014US8802849 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
08/12/2014US8802842 Method for the preparation of a crystalline form
08/12/2014US8802841 1,2-dideoxy-1,2-diamino oligosaccharides and polysaccharides and derivatives thereof
08/12/2014US8802840 Bicyclic nucleosides and nucleotides as therapeutic agents
08/12/2014US8802832 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
08/12/2014US8802831 Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
08/12/2014US8802830 Synthesis of epirubicin from 13-dihydrodaunorubicine
08/12/2014US8802826 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
08/12/2014US8802737 Method for improving tetracycline-resistance of Acinetobacter baumannii
08/12/2014US8802736 High concentration capsaicinoid pain relief composition
08/12/2014US8802735 (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
08/12/2014US8802734 Method of treating or preventing pain
08/12/2014US8802733 Aldehyde dehydrogenase inhibitors as novel depigmenting agents
08/12/2014US8802732 Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect
08/12/2014US8802731 N-acetyl beta alanine methods of use
08/12/2014US8802730 Increasing glutathione levels for therapy
08/12/2014US8802728 Analgesic compounds, methods, and formulations
08/12/2014US8802727 Pharmaceutically acceptable salts of betulinic acid derivatives
08/12/2014US8802726 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
08/12/2014US8802725 Transition metal complexes of a bis[thiohydrazine amide] compound
08/12/2014US8802724 Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
08/12/2014US8802723 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
08/12/2014US8802722 Benzopyran compounds as melanogenesis modifiers and uses thereof
08/12/2014US8802721 Thiophene compounds for inflammation and immune-related uses
08/12/2014US8802720 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
08/12/2014US8802719 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
08/12/2014US8802718 Composition for preventing the occurrence of cardiovascular event in multiple risk patient
08/12/2014US8802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
08/12/2014US8802716 IAP binding compounds
08/12/2014US8802715 Crystal forms of saxagliptin and processes for preparing same
08/12/2014US8802714 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
08/12/2014US8802713 3-alkoxy-1-phenylpyrazole derivatives and pesticides
08/12/2014US8802712 Pyrazoloquinolines
08/12/2014US8802711 TRPV1 antagonists
08/12/2014US8802710 Metronidazole esters for treating rosacea
08/12/2014US8802709 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
08/12/2014US8802707 Method of treating and/or preventing cancers using Sartans and/or Statins to modulate VDR, and/or PPAR, and/or GCR and/or CB1 receptors; in conjunction with certain bacteriostatic antibiotics
08/12/2014US8802706 Method for treating fibromyalgia
08/12/2014US8802705 Pharmaceutical containing PPAR delta agonist
08/12/2014US8802704 Oxadiazole derivatives
08/12/2014US8802703 Arylamino N-heteraryl compounds as MEK inhibitors
08/12/2014US8802702 Compounds for reducing drug resistance and uses thereof
08/12/2014US8802701 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
08/12/2014US8802700 Modulators of ATP-Binding Cassette transporters
08/12/2014US8802699 Quinuclidine derivatives and medicinal compositions containing the same
08/12/2014US8802698 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
08/12/2014US8802697 Inhibitors of the fibroblast growth factor receptor
08/12/2014US8802696 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
08/12/2014US8802695 Apoptosis signal-regulating kinase 1 inhibitors
08/12/2014US8802694 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
08/12/2014US8802693 Azaadamantane derivatives and methods of use
08/12/2014US8802692 Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
08/12/2014US8802691 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
08/12/2014US8802690 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
08/12/2014US8802689 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
08/12/2014US8802688 Substituted acetyl-coa carboxylase inhibitors
08/12/2014US8802687 Cadherin-11 inhibitors and methods of use thereof
08/12/2014US8802686 Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine
08/12/2014US8802685 Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
08/12/2014US8802683 Compounds for use in treatment of mucositis
08/12/2014US8802682 Compound useful for the treatment of degenerative and inflammatory diseases
08/12/2014US8802681 Pharmaceutical compositions with attenuated release of phenolic opioids
08/12/2014US8802680 Compositions, methods and kits for treating leukemia
08/12/2014US8802679 Glycine compound
08/12/2014US8802678 Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802674 Aminopyrimidine derivatives as LRRK2 modulators
08/12/2014US8802672 Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
08/12/2014US8802671 Quinoline derivatives as antibacterial agents
08/12/2014US8802670 Pharmaceutical compounds
08/12/2014US8802669 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
08/12/2014US8802668 Hematopoietic neoplasm chemotherapy
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014US8802666 Inhibitors of cyclophilins and uses thereof
08/12/2014US8802665 Pyrrolidine derivatives
08/12/2014US8802664 Benzazole derivatives as histamine H4 receptor ligands
08/12/2014US8802663 Pyrazole oxadiazole derivatives as S1P1 agonists
08/12/2014US8802662 Anti-hepatitis C composition and method for preparing drug for inhibiting hepatitis C viruses or treating hepatitis C
08/12/2014US8802661 C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
08/12/2014US8802660 De novo synthesis of glucocorticoids in the epidermis and its uses and applications
08/12/2014US8802658 Compositions for oral administration of zoledronic acid or related compounds for treating disease
08/12/2014US8802657 Compounds useful as Raf kinase inhibitors
08/12/2014US8802656 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
08/12/2014US8802655 4-hydroxybenzomorphans
08/12/2014US8802653 Deodorant compositions
08/12/2014US8802652 Rehydratable polysaccharide particles and sponge
08/12/2014US8802651 Hyaluronic acid in the enhancement of lens regeneration
08/12/2014US8802650 Methods of using human milk oligosaccharides for improving airway respiratory health
08/12/2014US8802648 Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 7860